3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
10
Unknown
3
Active not recruiting
3
Withdrawn
1
Terminated
1
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
23
Squamous Cell Carcinoma of Head and Neck
14
Head and Neck Neoplasms
12
Lung Neoplasms
10
Uterine Cervical Neoplasms
9
Neoplasms
9
Cholangiocarcinoma
5
Carcinoma, Squamous Cell
5
Carcinoma
5
Mesothelioma, Malignant
4
Carcinoma, Hepatocellular
4
Tongue Neoplasms
3
Small Cell Lung Carcinoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Breast Neoplasms
3
Biliary Tract Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Interventions
Docetaxel
3
Gene Expression Profiling
2
vandetanib
1
Therapeutics
1
Taxes
1
Radiotherapy
1
Polymerase Chain Reaction
1
Microarray Analysis
1
Immunohistochemistry
1
Hypericum extract LI 160
1
Everolimus
1
Erlotinib Hydrochloride
1
Electrophoresis, Polyacrylamide Gel
1
Cisplatin
1
Carboplatin
1
Biopsy
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Salivary Gland Neoplasms
×
Cisplatin
×
Clear all
NCT00084435
2012-06-14
S0217
SWOG Cancer Research Network
Phase 2
Withdrawn